Critical Care Prophylaxis, Nutrition & Infection Prevention

Critical Care Prophylaxis, Nutrition & Infection Prevention

Optimizing outcomes in neurocritical care requires rigorous systemic intensive care support that runs parallel to primary neurosurgical and neuromedical therapies. Neurologically critically ill patients are uniquely vulnerable to systemic complications—including stress-induced mucosal ulceration, secondary ischemic brain injury from glycemic volatility, hypercatabolic malnutrition, and device-associated hospital-acquired infections. A disciplined, evidence-based approach to prophylaxis, metabolic support, and infection prevention is essential to mitigate secondary brain injury and systemic organ dysfunction.

Stress Ulcer Prophylaxis (SUP) in Neurocritical Care

Pathophysiology of Stress-Related Mucosal Disease (SRMD)

Critically ill patients experience visceral hypoperfusion secondary to sympathetic overactivation, splanchnic vasoconstriction, systemic hypotension, and hypovolemia. Decreased gastric mucosal blood flow impairs microvascular bicarbonate delivery, depletes mucus production, and disrupts the epithelial tight junctions, allowing luminal gastric acid ($HCl$) and pepsin to erode the mucosa.

In neurocritical care, patients are additionally predisposed to Cushing ulcers—distinctive, deep, and perforating peptic ulcers occurring in the setting of severe intracranial hypertension, traumatic brain injury, or brainstem injury. Increased intracranial pressure stimulates hypothalamic autonomic centers and the vagal motor nucleus, causing excessive parasympathetic vagal discharge. Hyperstimulation of postganglionic muscarinic ($M_1$ and $M_3$) receptors on gastric parietal cells triggers massive, unchecked hydrochloric acid secretion through the $H^+/K^+$ ATPase pump.

Evidence-Based Indications for SUP

The 2024 SCCM/ASHP guideline identifies coagulopathy, shock, and chronic liver disease as likely important risk factors. It does not find firm evidence that mechanical ventilation alone is an independent risk factor. Consider the full bleeding risk, including the neurologic context, rather than automatically treating every intubation as a definite indication.

Use a low-dose PPI or H2 blocker when prophylaxis is indicated, and stop when the relevant risk has resolved. Enteral nutrition can reduce risk but does not necessarily replace prophylaxis in a patient with significant risk factors. Prior bleeding, treatment exposure, and clinical circumstances may affect individual decisions. Prophylaxis is distinct from treatment of established GI hemorrhage.

Pharmacologic Comparison: PPIs vs. $H_2$RAs

Glycemic Control in Acute Brain Injury

Neurotoxic Mechanisms of Hyperglycemia

Stress hyperglycemia is triggered by excessive sympathoadrenal discharge, endogenous cortisol release, glucagon secretion, and systemic insulin resistance. In acute brain injury (ischemic stroke, ICH, aSAH, and TBI), serum glucose $> 180\text{ mg/dL}$ produces pronounced secondary neurotoxicity:

• Lactic Acidosis: Hyperglycemia accelerates anaerobic glucose metabolism within ischemic tissue, generating marked intracellular lactic acidosis and tissue acidosis that destabilizes mitochondrial membranes.
• Reactive Oxygen Species ($ROS$): Excessive glucose influx drives mitochondrial electron transport chain overload, generating superoxide radicals, peroxynitrite, and oxidative lipid peroxidation.
• Blood-Brain Barrier Breakdown: Hyperglycemia upregulates matrix metalloproteinase-9 ($MMP-9$), digesting vascular endothelial basement membranes and precipitating vasogenic edema and hemorrhagic transformation.

The NICE-SUGAR Trial & Contemporary Targets

Historically, the 2001 Leuven trial suggested that "tight" glycemic control ($80\text{--}110\text{ mg/dL}$) dramatically reduced critical illness mortality. However, the landmark NICE-SUGAR trial (2009; 6,104 patients) definitively refuted this hypothesis:

• Intensive insulin therapy ($80\text{--}110\text{ mg/dL}$) produced a increase in severe hypoglycemia ($< 40\text{ mg/dL}$; $6.8\%$ vs $0.5\%$).
• Intensive therapy resulted in a significant increase in 90-day all-cause mortality ($27.5\%$ vs $24.9\%$; Odds Ratio $1.14$).

Neuroglycopenia in the Neuro-ICU

Cerebral microdialysis studies demonstrate that the injured brain is exceptionally vulnerable to systemic glucose drops. Lowering systemic glucose to $< 100\text{ mg/dL}$ frequently produces cerebral neuroglycopenia (brain interstitial glucose $< 0.8\text{ mmol/L}$) and cellular energy crisis (lactate-to-pyruvate ratio $LPR > 40$), triggering irreversible secondary neuronal necrosis even when systemic blood glucose remains technically "normal."

Enteral Nutrition Support & Metabolic Demands

Hypermetabolism and Hypercatabolism in Brain Injury

Severe acute brain injury induces a profound systemic hypermetabolic state. In severe TBI and status epilepticus, the hyperadrenergic state can increase energy expenditure, with considerable patient-to-patient variation. Protein breakdown accelerates, resulting in massive urinary nitrogen loss ($> 20\text{--}30\text{ g/day}$) and rapid depletion of somatic lean muscle mass.

Timing & Route of Nutritional Support

• Early Enteral Nutrition (EEN): Enteral feeding should be initiated within $24\text{ to }48\text{ hours}$ of neuro-ICU admission once hemodynamic resuscitation is complete.

• Physiologic Benefits: Luminal nutrients stimulate gut mucosal blood flow, maintain intestinal epithelial tight junctions, stimulate secretory $IgA$ production, and prevent bacterial translocation through the gut barrier, significantly reducing systemic sepsis and ventilator-associated pneumonia.

• Enteral vs. Parenteral: Enteral nutrition ($EN$) is strongly preferred over total parenteral nutrition ($TPN$). Parenteral support is selected when enteral feeding is contraindicated or persistently insufficient, with timing based on nutritional risk and clinical guidance.

• Energy and protein: Prefer measured expenditure when available and advance support according to illness phase, tolerance, nutritional risk, and local guidance rather than delivering a fixed full 25–30 kcal/kg immediately to every unstable patient. Protein needs are individualized. Screen for refeeding risk; replace thiamine and relevant electrolytes and monitor phosphate, potassium, magnesium, glucose, and fluid balance while advancing nutrition.

Gastric Residual Volumes (GRVs) & Post-Pyloric Feeding

• Routine cessation of enteral nutrition for moderate gastric residual volumes ($GRV < 250\text{--}500\text{ mL}$) is no longer recommended, as it causes severe nutritional deficits without reducing aspiration pneumonia.
• If gastroparesis or persistent intolerance occurs, administer prokinetic agents (metoclopramide $10\text{ mg}$ IV q6h or low-dose erythromycin $125\text{--}250\text{ mg}$ IV q8h).
• If high aspiration risk or intolerance persists, place a post-pyloric (nasoduodenal or nasojejunal) feeding tube.

ICU-Acquired Infection Prevention: Device Bundles

Critically ill neurologic patients frequently require invasive intravascular lines and indwelling urinary catheters, placing them at high risk for hospital-acquired bacteremia and urosepsis.

Central Line-Associated Bloodstream Infection (CLABSI) Bundle

Strict adherence to the evidence-based CLABSI bundle dramatically reduces catheter infections:

1. Hand Hygiene: Thorough hand washing or alcohol-based rub prior to catheter insertion and manipulation.
2. Maximal Sterile Barrier Precautions: The operator must wear cap, mask, sterile gown, and sterile gloves; the patient is covered with a full-body sterile drape.
3. Chlorhexidine Skin Antisepsis: Prepare insertion site with $> 0.5\%$ chlorhexidine gluconate in $70\%$ isopropyl alcohol; allow to dry completely according to the product instructions.
4. Optimal Site Selection: Avoid femoral vein catheterization in adult patients due to high rates of thrombosis and bacterial colonization. The subclavian site carries the lowest infection risk, followed by the internal jugular vein.
5. Daily Review and Prompt Removal: Daily assessment of catheter necessity with immediate removal of unneeded lines is the important component of the CLABSI prevention bundle.

Catheter-Associated Urinary Tract Infection (CAUTI) Bundle

Indwelling urinary catheters are a leading source of secondary bacteremia and septic shock in the ICU:

1. Restrict Indications: Place urinary catheters strictly for objective indications: acute urinary retention, hourly urine output titration in hemodynamic shock or active intracranial pressure resuscitation, and selected open sacral/perineal wounds in an incontinent patient when the benefits justify the catheter risk.
2. Aseptic Insertion: Use sterile equipment, sterile gloves, and sterile drape during placement.
3. Closed Drainage System: Maintain an uninterrupted, sterile closed drainage circuit; never disconnect catheter and tubing.
4. Unobstructed Downward Flow: Keep collection bag continuously below the level of the bladder; avoid tubing kinks or loops.
5. Early Catheter Removal: Reassess need during daily multidisciplinary rounds. Implement nurse-driven Foley removal protocols once hourly titration is no longer required.

Skin Protection, Mobility, and Pain

Inspect pressure-prone skin, use an appropriate support surface, offload heels, and reposition according to tolerance while protecting the airway, spine, drains, and perfusion. Device-related pressure injury can occur under collars, tubing, masks, and splints; skin checks must include these areas. An unstable spine or active ICP crisis changes the mobilization plan rather than eliminating reassessment forever. Begin a coordinated progression from passive activity to sitting, standing, and walking when physiologically safe, with nursing, therapy, and the clinical team.

Neuropathic pain after cord injury or other neural damage can involve burning, electric, or stimulus-evoked pain that responds differently from incisional nociception. Gabapentin or pregabalin may be useful, but require renal adjustment and monitoring for sedation and respiratory effects, especially with opioids. Other agents, such as selected antidepressants, need attention to blood pressure, anticholinergic effects, arrhythmia, serotonin interactions, and the neurologic examination. Combine medication with positioning, rehabilitation, and treatment of the underlying cause. Do not use paralysis to mask pain or agitation.